Ikarian Capital »

Io Biotech shares owned by Ikarian Capital

Quarter-by-quarter ownership of Io Biotech (IOBT) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Io Biotech

Tip: Access up to 7 years of quarterly data

All positions including Io Biotech held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Io Biotech by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $554k 1.5M 0.36

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Io Biotech

Novo A/S
Ikarian Capital
Millennium Management
Marshall Wace
Morgan Stanley
Boothbay Fund Management
Renaissance Technologies
Point72 Asset Management
XTX Topco
Bridgeway Capital Management
Goldman Sachs Group
Virtu Financial
Geode Capital Management
Goss Wealth Management
Hilton Capital Management

View all funds holding Io Biotech